New drug trial aims to regrow hair and restore skin color
NCT ID NCT06602232
Summary
This early-stage study is testing an experimental drug called DR-01 in adults with alopecia areata (hair loss) or vitiligo (skin depigmentation). The main goal is to check the drug's safety and see if it shows any signs of helping regrow hair or restore skin color. Researchers will enroll about 80 participants to receive the treatment and monitor them closely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dren Investigational Site
RECRUITINGNorthridge, California, 91344, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGMiami, Florida, 33155, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGEvans, Georgia, 30809, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGMeridian, Idaho, 83642, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGIndianapolis, Indiana, 46250, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGWest Lafayette, Indiana, 47906, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
NOT_YET_RECRUITINGWorcester, Massachusetts, 01605, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGTroy, Michigan, 48084, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGChattanooga, Tennessee, 37421, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGCharlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGCoorparoo, Queensland, 4151, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGSouth Yarra, Victoria, 3141, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGFremantle, Washington, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGAuckland, 0632, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGChristchurch, 8013, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGGrafton, 1010, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.